| 1 | 26758979 | Pharmacological therapies for Angelman syndrome. | Wien Med Wochenschr | 2017 Jun |
1 |
| 2 | 27860204 | Angelman syndrome: Current and emerging therapies in 2016. | Am J Med Genet C Semin Med Genet | 2016 Dec |
1 |
| 3 | 30737032 | SNHG14 enhances gemcitabine resistance by sponging miR-101 to stimulate cell autophagy in pancreatic cancer. | Biochem Biophys Res Commun | 2019 Mar 19 |
10 |
| 4 | 30779068 | LncSNHG14 promotes the development and progression of bladder cancer by targeting miRNA-150-5p. | Eur Rev Med Pharmacol Sci | 2019 Feb |
1 |
| 5 | 31121484 | SNHG14 confers gefitinib resistance in non-small cell lung cancer by up-regulating ABCB1 via sponging miR-206-3p. | Biomed Pharmacother | 2019 Aug |
7 |
| 6 | 31252267 | SNHG14 silencing suppresses the progression and promotes cisplatin sensitivity in non-small cell lung cancer. | Biomed Pharmacother | 2019 Sep |
3 |
| 7 | 31704614 | SNHG14 stimulates cell autophagy to facilitate cisplatin resistance of colorectal cancer by regulating miR-186/ATG14 axis. | Biomed Pharmacother | 2020 Jan |
1 |
| 8 | 31858549 | Long noncoding RNA SNHG14 exerts oncogenic functions in lung adenocarcinoma through acting as a sponge to miR-613. | Eur Rev Med Pharmacol Sci | 2019 Dec |
2 |
| 9 | 31948764 | Long noncoding RNA SNHG14 promotes osteosarcoma progression via miR-433-3p/FBXO22 axis. | Biochem Biophys Res Commun | 2020 Mar 12 |
1 |
| 10 | 32432733 | Long noncoding RNA SNHG14 promotes malignancy of prostate cancer by regulating with miR-5590-3p/YY1 axis. | Eur Rev Med Pharmacol Sci | 2020 May |
1 |
| 11 | 32607966 | LncRNA SNHG14 aggravates invasion and migration as ceRNA via regulating miR-656-3p/SIRT5 pathway in hepatocellular carcinoma. | Mol Cell Biochem | 2020 Oct |
1 |
| 12 | 33059643 | LncRNA SNHG14 regulates the DDP-resistance of non-small cell lung cancer cell through miR-133a/HOXB13 pathway. | BMC Pulm Med | 2020 Oct 15 |
2 |
| 13 | 33071725 | Knockdown of SNHG14 Alleviates MPP<sup>+</sup>-Induced Injury in the Cell Model of Parkinson's Disease by Targeting the miR-214-3p/KLF4 Axis. | Front Neurosci | 2020 |
5 |
| 14 | 33278191 | Knockdown of Long Noncoding RNA SNHG14 Protects H9c2 Cells Against Hypoxia-induced Injury by Modulating miR-25-3p/KLF4 Axis in Vitro. | J Cardiovasc Pharmacol | 2021 Mar 1 |
3 |
| 15 | 33553684 | Influence of pentoxifylline on gene expression of PAG1/ miR-1206/ SNHG14 in ischemic heart disease. | Biochem Biophys Rep | 2021 Mar |
2 |
| 16 | 33682607 | lncRNA SNHG14 promotes oncogenesis and immune evasion in diffuse large-B-cell lymphoma by sequestering miR-152-3p. | Leuk Lymphoma | 2021 Jul |
1 |
| 17 | 34529319 | LncRNA SNHG14 contributes to proinflammatory cytokine production in rheumatoid arthritis via the regulation of the miR-17-5p/MINK1-JNK pathway. | Environ Toxicol | 2021 Dec |
2 |
| 18 | 35349097 | SNHG14 Upregulation Was a Molecular Mechanism Underlying MPP<sup>+</sup> Neurotoxicity in Dopaminergic SK-N-SH Cells via SNHG14-miR-519a-3p-ATG10 ceRNA Pathway. | Neurotox Res | 2022 Apr |
4 |